Drug Search Results
More Filters [+]

Perifosine

Alternative Names: perifosine
Latest Update: 2024-03-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Akt Inhibitor,PI3K Modulator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: AEterna Zentaris
Company Location: MONTREAL A8 H3B 3V2
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Perifosine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Colorectal Cancer|Multiple Myeloma

Phase 2: Prostate Cancer|Waldenstrom Macroglobulinemia|Adenocarcinoma|Pancreatic Cancer|Breast Cancer|Leukemia|Colorectal Cancer|Renal Cell Carcinoma|Cervical Cancer|Lymphoma|Kidney Cancer|Multiple Myeloma|Astrocytoma|Ovarian Cancer|Oligodendroglioma|Non-Small-Cell Lung Cancer|Gliosarcoma|Brain Cancer|Glioblastoma|Sarcoma|Glioma|Lymphocytic Chronic B-Cell Leukemia|Alveolar Soft Part Sarcoma|Chronic Lymphoid Leukemia|Chondrosarcoma|Endometrial Cancer|Melanoma|Lymphoma, B-Cell|Head and Neck Cancer|Gastrointestinal Stromal Tumors

Phase 1: Multiple Myeloma|Preleukemia|Acute Megakaryoblastic Leukemia|Acute Lymphoid Leukemia|Liver Cancer|Colorectal Cancer|Kidney Cancer|Chronic Myeloid Leukemia|Precursor T-Cell Lymphoblastic Leukemia-Lymphoma|Myelogenous, Chronic, BCR-ABL Positive Leukemia|Acute Monocytic Leukemia|Acute Promyelocytic Leukemia|Chronic Myelomonocytic Leukemia|Myelodysplastic-Myeloproliferative Diseases|Diarrhea|Prostate Cancer|Renal Cell Carcinoma|Myelodysplastic Syndrome|Chronic Lymphoid Leukemia|Myeloproliferative Disorders|Myeloid, Accelerated Leukemia|Acute Myelomonocytic Leukemia|Adult T-Cell Leukemia-Lymphoma|Acute Myeloid Leukemia|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Acute Erythroblastic Leukemia|Oncology Solid Tumor Unspecified|Blast Crisis|Hypokalemia|Angina, Unstable|Hypertrophy, Left Ventricular|Ovarian Cancer|Lymphoma|Neuroblastoma|Hepatitis C, Chronic|Hepatitis B, Chronic|Glioblastoma|Contraception|Surgical Wound Infection|Angina Pectoris|Heart Failure, Acute|Angina, Stable|Heart Failure, Chronic|Myocardial Infarction|Pregnancy Outcomes|HIV Infections|Torsades de Pointes|Brain Cancer|Neuromyelitis Optica|Astrocytoma|Oligodendroglioma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT00590954

P2

Completed

Glioma|Brain Cancer

2019-11-11

NCI-2011-01409

P2

Completed

Oligodendroglioma|Gliosarcoma|Glioblastoma|Astrocytoma

2018-11-16

AAAM3801

P1

Completed

Astrocytoma|Glioblastoma|Oligodendroglioma|Brain Cancer

2017-10-27

NCT00776867

P1

Completed

Oncology Solid Tumor Unspecified

2017-07-01

Recent News Events